Shares of Walgreens Boots Alliance (WBA) fell during Tuesday's trading session following a Justice Department lawsuit alleging that the pharmacy chain knowingly provided millions of illegal drug prescriptions to customers, particularly involving opioids.
Catalysts co-hosts Madison Mills and Seana Smith break down the details and explore how this legal challenge could impact the pharmacy's proposed deal with Sycamore Partners, which could see the company go private.
For more expert insights and analysis on the latest market action, check out more Catalysts here.
This post was written by Angel Smith
